Pharmacielo Stock Probability of Future Pink Sheet Price Finishing Over 0.0521

Pharmacielo's future price is the expected price of Pharmacielo instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Pharmacielo performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
  
Please specify Pharmacielo's target price for which you would like Pharmacielo odds to be computed.

Pharmacielo Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmacielo for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmacielo can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pharmacielo is not yet fully synchronised with the market data
Pharmacielo is way too risky over 90 days horizon
Pharmacielo has some characteristics of a very speculative penny stock
Pharmacielo appears to be risky and price may revert if volatility continues
Pharmacielo has high likelihood to experience some financial distress in the next 2 years
Pharmacielo has accumulated 7.14 M in total debt with debt to equity ratio (D/E) of 0.71, which is about average as compared to similar companies. Pharmacielo has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharmacielo until it has trouble settling it off, either with new capital or with free cash flow. So, Pharmacielo's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharmacielo sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharmacielo to invest in growth at high rates of return. When we think about Pharmacielo's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 1.94 M. Net Loss for the year was (26.63 M) with loss before overhead, payroll, taxes, and interest of (4.17 M).
Pharmacielo has accumulated about 1.17 M in cash with (20.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Pharmacielo Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pharmacielo Pink Sheet often depends not only on the future outlook of the current and potential Pharmacielo's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharmacielo's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding149.3 M

Pharmacielo Technical Analysis

Pharmacielo's future price can be derived by breaking down and analyzing its technical indicators over time. Pharmacielo Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharmacielo. In general, you should focus on analyzing Pharmacielo Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Pharmacielo Predictive Forecast Models

Pharmacielo's time-series forecasting models is one of many Pharmacielo's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharmacielo's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Pharmacielo

Checking the ongoing alerts about Pharmacielo for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharmacielo help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pharmacielo is not yet fully synchronised with the market data
Pharmacielo is way too risky over 90 days horizon
Pharmacielo has some characteristics of a very speculative penny stock
Pharmacielo appears to be risky and price may revert if volatility continues
Pharmacielo has high likelihood to experience some financial distress in the next 2 years
Pharmacielo has accumulated 7.14 M in total debt with debt to equity ratio (D/E) of 0.71, which is about average as compared to similar companies. Pharmacielo has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharmacielo until it has trouble settling it off, either with new capital or with free cash flow. So, Pharmacielo's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharmacielo sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharmacielo to invest in growth at high rates of return. When we think about Pharmacielo's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 1.94 M. Net Loss for the year was (26.63 M) with loss before overhead, payroll, taxes, and interest of (4.17 M).
Pharmacielo has accumulated about 1.17 M in cash with (20.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Tools for Pharmacielo Pink Sheet

When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories